US Patent No. 10,231,908 B2: Galderma S.A., Lausanne, has patented a method of reducing hair loss in a patient undergoing chemotherapy, the method comprising topically applying a pharmaceutical composition comprising an effective amount of brimonidine or a pharmaceutically acceptable salt thereof to hair follicles with hair of the patient during the course of the chemotherapy....